John Wikstrand

13.5k total citations
139 papers, 6.4k citations indexed

About

John Wikstrand is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John Wikstrand has authored 139 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Cardiology and Cardiovascular Medicine, 23 papers in Surgery and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John Wikstrand's work include Blood Pressure and Hypertension Studies (37 papers), Heart Failure Treatment and Management (37 papers) and Cardiovascular Function and Risk Factors (29 papers). John Wikstrand is often cited by papers focused on Blood Pressure and Hypertension Studies (37 papers), Heart Failure Treatment and Management (37 papers) and Cardiovascular Function and Risk Factors (29 papers). John Wikstrand collaborates with scholars based in Sweden, United Kingdom and Norway. John Wikstrand's co-authors include Hans Wedel, John Kjekshus, Inger Wendelhag, Björn Fagerberg, G Berglund, Susanne Ljungman, Finn Waagstein, John J.V. McMurray, Stefan Agewall and Johannes Hulthe and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

John Wikstrand

136 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Wikstrand Sweden 46 4.7k 1.0k 975 881 442 139 6.4k
Alain Simon France 42 3.6k 0.8× 1.3k 1.3× 1.5k 1.6× 838 1.0× 454 1.0× 173 6.3k
Giuseppe Germanò Italy 19 5.3k 1.1× 1.1k 1.1× 934 1.0× 1.6k 1.8× 442 1.0× 71 7.3k
Arne Westheim Norway 32 5.8k 1.2× 970 0.9× 1.3k 1.4× 393 0.4× 924 2.1× 130 7.5k
John Goudevenos Greece 38 3.1k 0.7× 1.6k 1.6× 590 0.6× 723 0.8× 677 1.5× 194 6.3k
Livio Dei Italy 39 4.4k 0.9× 954 0.9× 1.0k 1.0× 325 0.4× 378 0.9× 205 6.0k
Michel White Canada 44 5.6k 1.2× 1.3k 1.2× 884 0.9× 822 0.9× 429 1.0× 204 7.4k
John R. Crouse United States 31 2.9k 0.6× 1.6k 1.6× 1.1k 1.2× 2.2k 2.5× 642 1.5× 56 6.4k
Henry J. Dargie United Kingdom 51 6.9k 1.5× 1.3k 1.3× 1.2k 1.3× 870 1.0× 426 1.0× 172 8.9k
Mona Fiuzat United States 46 5.3k 1.1× 800 0.8× 1.3k 1.3× 616 0.7× 492 1.1× 184 7.1k
Janice Pogue Canada 29 4.7k 1.0× 960 0.9× 635 0.7× 1.4k 1.6× 865 2.0× 43 7.8k

Countries citing papers authored by John Wikstrand

Since Specialization
Citations

This map shows the geographic impact of John Wikstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wikstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wikstrand more than expected).

Fields of papers citing papers by John Wikstrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Wikstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wikstrand. The network helps show where John Wikstrand may publish in the future.

Co-authorship network of co-authors of John Wikstrand

This figure shows the co-authorship network connecting the top 25 collaborators of John Wikstrand. A scholar is included among the top collaborators of John Wikstrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Wikstrand. John Wikstrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kotecha, Dipak, Marcus Flather, Douglas G. Altman, et al.. (2017). Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure. Journal of the American College of Cardiology. 69(24). 2885–2896. 172 indexed citations
2.
Feinstein, Matthew J., Pardeep S. Jhund, Joseph Kang, et al.. (2015). Do Statins Reduce the risk of Myocardial Infarction in Patients with Heart Failure? A Pooled Individual-Level Reanalysis of CORONA and GISSI-HF. European Journal of Heart Failure. 17(4). 434–441. 31 indexed citations
3.
Kristensen, Søren Lund, Lars Køber, Pardeep S. Jhund, et al.. (2014). International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction. Circulation. 131(1). 43–53. 58 indexed citations
4.
Latini, Roberto, Lars Gullestad, Serge Masson, et al.. (2012). Pentraxin-3 in Chronic Heart Failure: The CORONA and GISSI-HF Trials. European Journal of Heart Failure. 14(9). 992–999. 80 indexed citations
5.
Inglis, Sally C., John J.V. McMurray, Michael Böhm, et al.. (2010). Intermittent Claudication as a Predictor of Outcome in Patients with Ischaemic Systolic Heart Failure: Analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). European Journal of Heart Failure. 12(7). 698–705. 22 indexed citations
6.
Lorgelly, Paula, Andrew Briggs, Hans Wedel, et al.. (2009). An Economic Evaluation of Rosuvastatin Treatment in Systolic Heart Failure: Evidence from the CORONA Trial. European Journal of Heart Failure. 12(1). 66–74. 14 indexed citations
7.
8.
Harst, Pim van der, Liza S. M. Wong, Rudolf A. de Boer, et al.. (2008). Possible Association Between Telomere Length and Renal Dysfunction in Patients With Chronic Heart Failure. The American Journal of Cardiology. 102(2). 207–210. 42 indexed citations
9.
Veldhuisen, Dirk J. van, Halfdan Aass, Dia El Allaf, et al.. (2006). Presence and Development of Atrial Fibrillation in Chronic Heart Failure. European Journal of Heart Failure. 8(5). 539–546. 75 indexed citations
10.
Jaime, J., Judith A. O’Brien, Jennifer Kim, et al.. (2005). Economic Implications of Extended-Release Metoprolol Succinate for Heart Failure in the MERIT-HF Trial: A US Perspective of the MERIT-HF Trial. Journal of Cardiac Failure. 11(9). 647–656. 20 indexed citations
11.
Kjekshus, John, Peter Dunselman, Åke Hjalmarson, et al.. (2005). A Statin in the Treatment of Heart Failure? Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA): Study Design and Baseline Characteristics. European Journal of Heart Failure. 7(6). 1059–1069. 120 indexed citations
12.
Gullestad, Lars, John Wikstrand, Prakash Deedwania, et al.. (2005). What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker?. Journal of the American College of Cardiology. 45(2). 252–259. 89 indexed citations
13.
Wikstrand, John, Åke Hjalmarson, Finn Waagstein, et al.. (2002). Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure. Journal of the American College of Cardiology. 40(3). 491–498. 221 indexed citations
14.
Agewall, Stefan, John Wikstrand, M Suurküla, Lilian Tengborn, & Björn Fagerberg. (1994). Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease. Blood Coagulation & Fibrinolysis. 5(6). 895–904. 23 indexed citations
15.
Widgren, Bengt R., John Wikstrand, G Berglund, & O Andersson. (1992). Increased response to physical and mental stress in men with hypertensive parents.. Hypertension. 20(5). 606–611. 43 indexed citations
16.
Berglund, G, Ann Hellström, Susanne Ljungman, Marianne Hartford, & John Wikstrand. (1987). The relationship between obesity-related metabolic factors and vascular changes in early hypertension.. PubMed. 1(1). 25–30. 5 indexed citations
17.
Wikstrand, John, Hans Herlitz, & Göran Berglund. (1984). Acute and Subacute Haemodynamic Effects of Enalapril. Scandinavian Journal of Urology and Nephrology. 18(sup79). 81–85. 3 indexed citations
18.
Wikstrand, John & G Berglund. (1982). Antihypertensive treatment with beta-blockers in patients aged over 65.. BMJ. 285(6345). 850.1–850. 19 indexed citations
19.
Lindström, Björn, K Korsan-Bengtsen, Olof Jonsson, et al.. (1982). Electrically induced short-lasting tetanus of the calf muscles for prevention of deep vein thrombosis. British journal of surgery. 69(4). 203–206. 13 indexed citations
20.
Wilhelmsen, Lars, G Berglund, R Sannerstedt, et al.. (1979). Effect of treatment of hypertension in the primary preventive trial, Goteborg, Sweden.. British Journal of Clinical Pharmacology. 7(S2). 261S–265S. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alain Simon Breakdown of academic impact, for papers by Giuseppe Germanò Breakdown of academic impact, for papers by Arne Westheim Breakdown of academic impact, for papers by John Goudevenos Breakdown of academic impact, for papers by Livio Dei Breakdown of academic impact, for papers by Michel White Breakdown of academic impact, for papers by John R. Crouse Breakdown of academic impact, for papers by Henry J. Dargie Breakdown of academic impact, for papers by Mona Fiuzat Breakdown of academic impact, for papers by Janice Pogue
Rankless by CCL
2026